ME-344 Approval Status
ME-344 is a novel mitochondrial inhibitor in development for the treatment of ovarian cancer and small cell lung cancer.
Development Status and FDA Approval Process for ME-344
|Mar 8, 2012||Marshall Edwards Submits Investigational New Drug Application for Oncology Drug Candidate ME-344|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.